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CORRESPONDENCE
Highly Sensitive Chemiluminescent Method for the Detection of Maternal Cell Contamination in Human Cord
Blood Stored for Allotransplantation: The Experience of the Milano Cord Blood Bank
To the Editor: For the 50 cases examined, ApoB was informative for 21 samples,
whereas for the remaining samples D1S80 was useful.
Noninherited maternal allele was detected in 5 of the 21 CB
Among the questions to be answered regarding umbilical cord samples examined with ApoB; with D1S80, 5 additional samples
blood (CB) cell use for bone marrow reconstitution, one concerns were found contaminated of the 29 informative.
the level of contamination with maternal lymphocytes that could be The level of contamination, defined comparing the intensity of
responsible for severe graft-versus-host disease (GVHD) in immuno- the contaminating band with that of the standards, ranged from 1:100
suppressed recipients.1,2 to 1:2,500.
In the present study, we report data concerning the contamination The child paternal allele was detected in 3 of the 30 mothers
with maternal cells in 50 consecutive CB units; to this purpose, we whose newborn was heterozygous at the loci examined.
used polymerase chain reaction (PCR) amplification of minisatellite Figure 1 reports an example of ApoB minisatellite analysis.
sequences followed by chemiluminescent detection. The problem of contamination of CB units with maternal lympho-
CB was collected after delivery of term newborns as previously
described.3 Genomic DNA was extracted with the salting out
method4 from 500 mL of CB and mother’s EDTA whole blood.
Samples were handled in the preamplification area in a laminar
vertical air flow hood using dedicated positive displacement pipettes.
Apolipoprotein B gene (ApoB)5 and D1S806 minisatellite analysis
was performed.
Firstly, we performed a PCR assay of all samples using primers
that amplify the VNTR 3* of the ApoB gene. The VNTR was consid-
ered to be not informative when the mother was homozygous or had
the same alleles as the child. When ApoB was not informative, we
amplified the D1S80 polymorphic locus.
Each PCR reaction was performed in 50 mL final volume con-
taining 100 ng of genomic DNA, 50 mmol/L KCl, 10 mmol/L Tris-
HCl, pH 9.0, 1.5 mmol/L MgCl2 , 0.1% Triton X-100, 0.15 mmol/L
(for ApoB) or 0.4 mmol/L (for D1S80) of each primer, 36 mmol/L
of dCTP, 100 mmol/L of each dNTP (of a mix containing dATP,
dGTP, and dTTP), 60 mmol/L of biotin-labeled dCTP, and 3 U of
Taq DNA polymerase. PCR conditions and primer sequences were
those described elsewhere for ApoB5 and for D1S80.6
Seven microliters of PCR product was loaded on a 3% agarose
gel and electrophoresed for 16 hours with 11 TBE at 7 V/cm at
47C.
To assess the sensitivity of our test and to determine the magnitude
of the contamination with maternal cells in CB samples, standards
obtained mixing 50 ng/mL of DNA from two individuals with alleles
of different sizes for each VNTR polymorphism (ApoB, D1S80) at
the dilutions 1:500, 1:1,000, and 1:2,500 were amplified in parallel
with the other samples and loaded on the gel. After electrophoresis,
DNA was transferred from the gel into a Tropilon plus positively
charged nylon membrane (Tropix, Bedford, MA) by Southern blot-
ting.
DNA fragments generated in the PCR reaction were labeled
through the incorporation of biotinylated dCTP. The detection of
PCR products was obtained through two steps: (1) the conjugation
of streptavidin-alkaline phosphatase conjugate (Avidix-AP; Tropix)
to the biotin-labeled PCR products; and (2) the addition of CSPDR
substrate (Tropix), which decomposed upon enzymatic dephosphor-
ylation. The light emission, from the enzyme activated CSPDR sub-
strate resulted in a DNA band pattern that was imaged on x-ray film
(Kodak X-Omat AR; Eastman Kodak Co, Rochester, NY).
For the detection of PCR products, the CSPDR protocol Southern-
Light Nucleic Acid Detection Systems (Tropix) was followed.7,8
Exposure to x-ray film ranged from 15 minutes to 2 hours, de- Fig 1. Lane 1 shows a noncontaminated cord examined with
pending on the visualization of the contaminating band in the stan- ApoB. Lane 2 shows the respective mother. Lane 3 reports a contami-
dard diluted 1:2,500. Every test was performed twice to confirm the nated cord. Lane 4 shows the mother. The arrow indicates the band
due to maternal DNA contamination.results.
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cytes has been widely investigated. However, to our knowledge, the 2. Nathan DG: The beneficence of neonatal hematopoiesis. N
results available9-13 refer to numerically limited series and, to a cer- Engl J Med 321:1190, 1989
tain extent, are discordant depending on the method used. 3. Lazzari L, Corsini C, Curioni C, Lecchi L, Scalamogna M,
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comparable to that reported by Socie` et al,12 without resorting to 4. Miller SA, Dykes DD, Polesky HF: A simple salting out proce-
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Moreover, we were able to demonstrate an exchange of cells from Res 16:1215, 1988
child to mother through the placenta/uterus interface, supporting 5. Boerwinkle B, Xiong W, Fourest E, Chan L: Rapid typing of
previously published studies that have shown the passage of fetal tandemly repeated hypervariable loci by the polymerase chain reac-
cells into the maternal circulation during pregnancy.10,14 tion: Application of apolipoprotein B 3* hypervariable region. Proc
However, we are aware that our series is limited, too; the combina- Natl Acad Sci USA 86:212, 1989
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Mycosis Fungoides and Total Skin Electron Beam Radiation
To the Editor: The survival experiences of patients receiving less optimal ver-
sions of TSE were compared with the experiences of patients man-
We are writing to clarify comments concerning total skin electron aged with other topical therapies in 4 studies. These included con-
beam radiation (TSE) made by Diamandidou et al1 in their compre- temporaneous,5 concurrent,4,6 and randomized7 controls. All 4 studies
hensive review of mycosis fungoides and the Sezary syndrome. showed that premodern TSE achieved only moderate rates of com-
The technical description of TSE in the review did not distinguish plete remission and was not associated with improved survival. For
between premodern and modern methods of TSE. Modern TSE is example, in the randomized trial,7 combined premodern TSE and
defined by a skin surface dose of 35 to 36 Gy delivered with electrons systemic chemotherapy was no better than conservative management
of at least 4 MeV energy.2-4 This TSE optimizes the distribution of in 103 randomized patients, although it should be noted that a major-
dose within the main target volume (epidermis and dermis, to a depth ity of the patients in this trial had nodal and visceral disease (and
of 5 mm; including blood present in the skin during radiation). It also were stage IV). In contrast, both Hoppe et al8,9 and Jones and Thor-
increases the penetration of electrons to between 2 to 3 cm to encom- son4 have separately shown that more optimal versions of TSE are
pass many superficial lymph nodes.2 These attributes are clinically associated with improved progression-free and overall survivals.3,8
significant. A meta-analysis of the main technical parameters of TSE Kim et al10 have just reported a comparison of mechlorethamine
showed that modern TSE is associated with very high rates of com- versus a predominantly historical and essentially premodern TSE
plete remission, with even advanced disease having a rate in excess control group for only stage IA disease. None of 34 TSE patients
of 70%.2,3 Of course, a key question is whether modern TSE improves and 3 of 73 mechlorethamine patients died of MF (5% difference
at 10 years; P  .18). Recently, Jones and Thorson4 were able tosurvival as compared with premodern TSE or no TSE.
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